Glofitamab Combined with Poseltinib and Lenalidomide for Relapsed/refractory Diffuse Large B Cell Lymphoma: Interim Analysis of GPL Study.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined